Dupilumab
Showing 1 - 25 of 198
Atopic Dermatitis Trial (Dupilumab - Discontinuation, Dupilumab - Dose Reduction, Dupilumab - Standard Dose)
Not yet recruiting
- Atopic Dermatitis
- Dupilumab - Discontinuation
- +2 more
- (no location specified)
Nov 2, 2023
Dupilumab in Prurigo Nodularis: An Observational Study
Not yet recruiting
- Prurigo Nodularis
- Dupilumab
- (no location specified)
Aug 7, 2023
Bullous Pemphigoid Trial (dupilumab)
Temporarily not available
- Bullous Pemphigoid
- dupilumab
- (no location specified)
Jun 7, 2023
Dermal Hypersensitivity Reaction Trial in Ann Arbor (Dupilumab)
Not yet recruiting
- Dermal Hypersensitivity Reaction
- Dupilumab
-
Ann Arbor, MichiganUniversity of Michigan
Aug 21, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Charleston, Charlottesville (Dupilumab)
Recruiting
- Chronic Rhinosinusitis With Nasal Polyps
- Dupilumab
-
Charleston, South Carolina
- +1 more
Jul 27, 2023
Atopic Dermatitis Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
- Dupilumab
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 4, 2023
NSCLC Trial (Dupilumab, Cemiplimab)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Dupilumab
- Cemiplimab
- (no location specified)
Oct 12, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema Trial in Rotterdam (Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- Atopic Dermatitis Eczema
- Dupilumab
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Aug 22, 2023
Eosinophilic Oesophagitis Trial (Dupilumab, Placebo)
Not yet recruiting
- Eosinophilic Oesophagitis
- Dupilumab
- Placebo
- (no location specified)
Oct 19, 2023
Healthy Volunteer Trial in Saint Paul, Springfield (Dupilumab (SAR231893))
Completed
- Healthy Volunteer
- Dupilumab (SAR231893)
-
Saint Paul, Minnesota
- +1 more
Jul 28, 2023
Prurigo Nodularis Trial (Dupilumab SAR231893 (REGN668))
Not yet recruiting
- Prurigo Nodularis
- Dupilumab SAR231893 (REGN668)
- (no location specified)
Oct 11, 2023
Eosinophilic Gastritis, Eosinophilic Duodenitis, Eosinophilic Gastrointestinal Disease Trial (Dupilumab Dose 1, Dupilumab Dose
Not yet recruiting
- Eosinophilic Gastritis
- +2 more
- Dupilumab Dose 1
- +2 more
- (no location specified)
Apr 14, 2023
Healthy Volunteers Trial in Miami (Dupilumab (SAR231893))
Completed
- Healthy Volunteers
- Dupilumab (SAR231893)
-
Miami, FloridaClinical Pharmacology of Miami-Site Number:8400001
Jul 28, 2023
Healthy Volunteers Trial in Saint Paul (Dupilumab (SAR231893))
Completed
- Healthy Volunteers
- Dupilumab (SAR231893)
-
Saint Paul, MinnesotaPrism Research-Site Number:840001
Jul 28, 2023
Bronchial Inflammation, Small Airways Disfunction and Mucous
Not yet recruiting
- Asthma; Eosinophilic
- Dupilumab
- (no location specified)
Mar 15, 2023
Skin Diseases Trial in Chicago (Dupilumab)
Not yet recruiting
- Skin Diseases
- Dupilumab
-
Chicago, IllinoisAnn & Robert H. Lurie Children's Hospital of Chicago
Jan 9, 2023
Dermatitis Atopic Trial (dupilumab)
Not yet recruiting
- Dermatitis Atopic
- dupilumab
- (no location specified)
Aug 1, 2023
Asthma, Allergic Trial in San Antonio (Dupilumab, House Dust Mites (HDM), Placebo)
Not yet recruiting
- Asthma, Allergic
- Dupilumab
- +2 more
-
San Antonio, Texas
- +1 more
Jan 27, 2023
Atopic Dermatitis, Atopic Dermatitis Eczema, Eczema Trial in San Francisco (Dupilumab)
Recruiting
- Atopic Dermatitis
- +3 more
- Dupilumab
-
San Francisco, CaliforniaUCSF Psoriasis and Skin Treatment Center
Jan 25, 2023
Quality of Life in Male and Female Adult Severe Asthma Treated
Not yet recruiting
- Asthma
- (no location specified)
Aug 31, 2023
Alopecia Areata Trial in United States (Dupilumab, Placebo)
Not yet recruiting
- Alopecia Areata
- Dupilumab
- Placebo
-
Irvine, California
- +3 more
May 10, 2023
Dupilumab in Participants =6 Years With Atopic Dermatitis
Recruiting
- Atopic Dermatitis
-
Berlin, GermanyInvestigational Site Number :
Sep 18, 2023
Atopic Dermatitis Trial in Newark (BSI-045B, Dupilumab)
Not yet recruiting
- Atopic Dermatitis
- BSI-045B
- Dupilumab
-
Newark, DelawareBiosion USA, Inc.
Jul 7, 2023
Describe Post-authorisation Early Clinical Experience of
Active, not recruiting
- Asthma
- No intervention
-
Chilly-Mazarin, FranceInvestigational Site Number :
Sep 26, 2023
Pruritus Trial in Jacksonville (Dupilumab 300Mg Solution for Injection)
Recruiting
- Pruritus
- Dupilumab 300Mg Solution for Injection
-
Jacksonville, FloridaMayo Clinic Florida
Nov 30, 2022